Cargando…
Tumour suppression associated with expression of human insulin-like growth factor II.
Recent circumstantial evidence has implicated Insulin-like growth factor II in the genesis of several tumour types, notably developmental tumours (Scott et al., 1985; Schofield & Tate, 1987; Wilkins et al., 1989). This type of tumour, thought to originate during the defective differentiation of...
Autores principales: | Schofield, P. N., Lee, A., Hill, D. J., Cheetham, J. E., James, D., Stewart, C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972407/ https://www.ncbi.nlm.nih.gov/pubmed/2039693 |
Ejemplares similares
-
Mammary cancer in transgenic mice expressing insulin-like growth factor II (IGF-II)
por: Bates, P., et al.
Publicado: (1995) -
Insulin‐like growth factor‐II and bioactive proteins containing a part of the E‐domain of pro‐insulin‐like growth factor‐II
por: van Doorn, Jaap
Publicado: (2020) -
Neurotropic and modulatory effects of insulin-like growth factor II in Aplysia
por: Kukushkin, Nikolay Vadimovich, et al.
Publicado: (2019) -
MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer
por: Guo, S T, et al.
Publicado: (2013) -
Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I.
por: Durrant, L. G., et al.
Publicado: (1991)